Enzoloy H Tablet is a combination pharmaceutical formulation containing Trypsin (48 mg), Rutoside (100 mg), Bromelain (90 mg), and Harpagoside (50 mg), designed to provide anti-inflammatory, analgesic, and fibrinolytic effects. Trypsin, a proteolytic enzyme, facilitates the breakdown of proteins and aids in reducing inflammation and edema by promoting the degradation of inflammatory mediators. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, thereby improving microcirculation and reducing capillary permeability. Bromelain, a proteolytic enzyme derived from pineapple stems, enhances anti-inflammatory activity by modulating cytokine production and reducing swelling and pain associated with trauma or surgery. Harpagoside, an active constituent of Harpagophytum procumbens (devil’s claw), is known for its analgesic and anti-arthritic properties, contributing to the alleviation of musculoskeletal discomfort. The synergistic action of these components makes Enzoloy H Tablet effective in the management of inflammatory conditions such as osteoarthritis, soft tissue injuries, postoperative inflammation, and edema. It is indicated for patients requiring reduction of pain and inflammation with improved tissue repair. Enzoloy H should be administered under medical supervision, considering contraindications and potential drug interactions.